Essential APIs for the U.S. by source location| Statista

As of 2021, almost three quarters of all production sites of essential active pharmaceutical ingredients for the U.S. market were located outside the United States.

Distribution of manufacturing locations of essential active pharmaceutical ingredients (APIs) for the U.S. market as of 2021

Characteristic	Share of manufacturing locations
No U.S. source	72%
One U.S. source	22%
Two or more U.S. sources	6%

• No U.S. source 72%

• One U.S. source 22%

• Two or more U.S. sources 6%

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

September 2021

More information

Region

Worldwide, China, India

Survey time period

As of May 2021

Supplementary notes

Essential APIs: based on the 2020 FDA list of critical APIs, including: aspirin, acetaminophen, nitroglycerine, naloxone, etc.

Citation formats

Access all statistics starting from $2,388 USD yearly ^*

* For commercial use only

For single users

$0 USD

Always free

Access limited to Free Statistics. Premium Statistics are not included.

Free Statistics

Based on your interests

For single users

$199 USD

per month, billed annually ¹

Buy now

Free Statistics
Premium Statistics

For teams of up to 5 people

$1,299 USD

per month, billed annually ¹

Buy now

Free + Premium Statistics
Reports
Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Leading companies trust Statista:

Related reports: Available to download in PDF or PPTX format

All data
in one format

Active pharmaceutical ingredients (APIs) and excipients

28 page/s
English
pptx
Detailed references

Everything on "Active pharmaceutical ingredients (APIs) and excipients" in one document: edited and divided into chapters, including detailed references.

Go to report